Skip to content

Omada Health

US · OMDA #3099 by market cap Listed 2025
11.87 -0.63 -5.04%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Price chart

Pre-market 12.23 -2.16%
After-hours 11.81 -0.51%
Overnight 12.15 -2.80%
24.9911.8711.872026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on OMDA?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bearish
  • Recent price momentum is -42.3% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 15.0% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days D → E

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2849 U.S. stocks StockVane covers.

Last computed: 2026-11-21 14:27 UTC

Data coverage: 5 of 6 factors. Missing data is not a zero score.

Overall C-

The radar needs all six factors. Available grades are shown below.

Valuation D

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 52.5x Better than 9%
Forward P/E 46.1x Better than 8%
Price / Sales 2.7x Better than 48%
P/E vs own 5-yr range 81st pctl Better than 25%
Growth N/A

How fast revenue, profit and free cash flow are compounding.

Not enough data to grade this factor.

Profitability C

How much profit the business keeps from each dollar of sales and capital.

Gross margin 65.7% Better than 79%
Operating margin -4.6% Better than 17%
Net margin -4.9% Better than 19%
Momentum D+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -50.3% Better than 5%
6-month return -28.1% Better than 20%
12-month return (ex latest month) 2.0% Better than 36%
Distance below 52-week high 53.4% Better than 16%
Financial Health A-

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 3.6x Better than 78%
Debt to assets 0.0% Better than 100%
Interest coverage -4.0x Better than 17%
Analyst View A

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 88.9% Better than 71%
Upside to average target 133.1% Better than 88%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -17.17%
1M -38.62%
3M -49.94%
6M -28.15%
YTD -24.78%
1Y -34.67%

Key statistics

Price & volume

Prev close
12.50
Open
12.29
Day range
11.76 - 12.64
Avg price
12.02
Volume
1.71M
Turnover
20.57M
Amplitude
7.06%
52-week range
10.28 - 25.45

Valuation

P/E
-54.20
P/E (TTM)
52.52
P/B
2.70
EPS
-0.22
Net profit
-13.59M
Net assets
273.15M

Share structure

Market cap
736.39M
Float cap
666.96M
Shares out
62.04M
Float shares
56.19M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2025-06-06
52-week range 10% of range
10.28 25.45

53.4% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-4.79M net over the window

Short interest

Shares short
9.16M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Omada Health (OMDA)?

Omada Health last traded at 11.87. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Omada Health's market cap?

About 736.39M.

What is the P/E ratio of Omada Health?

The trailing twelve-month P/E is 52.52. The Valuation tab shows it against the stock's own five-year range.

Does Omada Health pay a dividend?

Omada Health does not currently pay a regular dividend.

Is Omada Health a buy according to analysts?

The consensus of 9 analysts is a Buy rating, with an average 12-month price target of 27.67, which implies 133.1% upside from the current price. This is not investment advice.

What is Omada Health's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Omada Health a E (Strong Sell). Below its 200-day average and near the bottom of the universe on momentum. Not investment advice.

Quote time 2026-11-20 20:02:43 · For reference only, not investment advice and not tailored to your situation.

Omada Health discussion 0 comments

Add a comment